PASCAL Feasibility Study

May 18, 2026 updated by: University of Minnesota

Feasibility of Using a Conversational Agent for Promoting Smoking Cessation Treatment Utilization

The goal of this randomized study is to assess if a conversational agent (or chatbot) that the investigators have developed to help with quitting smoking is acceptable to people trying to quit smoking and to also collect initial information regarding its effectiveness.

In this study, some participants trying to quit smoking will be provided with this chatbot while other participants will not be

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Sheena Study Coordinator
  • Phone Number: 612-626-5981
  • Email: gahmx008@umn.edu

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • University of Minnesota

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Identify as Black or African American
  • Be at least 21 years of age
  • Meet a minimum smoking amount
  • Be willing to make a quit attempt in the next 30 days
  • Have a smartphone capable of downloading and running the study app
  • Be able to upload data from the app
  • Agree to receive text message reminders about study activities
  • Be a native English speaker
  • Reside in Minnesota.

Exclusion Criteria:

  • Medicinal nicotine use would require careful monitoring by a healthcare professional
  • Medical condition or medication used likely to significantly interfere with study outcomes or to be significantly affected by changes in smoking behavior
  • Are pregnant or breastfeeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: control group
no chatbot is provided
Experimental: chatbot assisted smoking trigger management
a chatbot will alert during predicted high risk smoking times and suggest approaches to manage potential smoking triggers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of trial procedures
Time Frame: 1 day
The proportion of enrolled participants who download the study app
1 day
Feasibility of study procedures
Time Frame: 2 weeks
The proportion of participants (among those who downloaded the app) who complete the week 2 post-quit visit
2 weeks
Health Information Technology Usability Evaluation Scale (Health-ITUES)
Time Frame: 2 weeks
This scale will be used to access the acceptability of study app. The scale consists of 20 questions scored from 1 to 5 with higher values indicating more positive response
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average number of daily interactions with the study app
Time Frame: 2 weeks
2 weeks
The average number of cigarettes smoked per day
Time Frame: 2 weeks
2 weeks
Average number of nicotine lozenges used
Time Frame: 2 weeks
2 weeks
The proportion of participants who complete the week 8 post-quit visit
Time Frame: 8 weeks
8 weeks
The proportion of participants not smoking for the 7 day period before the week 2 visit
Time Frame: 2 weeks
2 weeks
The proportion of participants not smoking for the 7 day period before the week 8 visits
Time Frame: 8 weeks
8 weeks
The proportion of participants not smoking at all between the quit date and the week 2 visit
Time Frame: 2 weeks
2 weeks
The proportion of participants not smoking at all between the quit date and the week 8 visit
Time Frame: 8 weeks
8 weeks
Motivation to quit smoking
Time Frame: 2 weeks
Using a 1 - 10 scale on the contemplation to quit ladder (1 - no interest in quitting; 10 - will never smoke again)
2 weeks
Brief Questionnaire of Smoking Urges (QSU-Brief)
Time Frame: 2 weeks
Questionnaire assessing craving severity. Range for total score is 10 - 70 with higher score indicating greater craving
2 weeks
The Minnesota Nicotine Withdrawal Scale (MNWS)
Time Frame: 2 weeks
Questionnaire assessing withdrawal symptom severity. Range for total score is 0 - 36 with higher score indicating greater withdrawal symptoms
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Kotlyar, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 15, 2026

Primary Completion (Estimated)

May 15, 2027

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

December 11, 2025

First Submitted That Met QC Criteria

December 22, 2025

First Posted (Actual)

December 24, 2025

Study Record Updates

Last Update Posted (Actual)

May 19, 2026

Last Update Submitted That Met QC Criteria

May 18, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00026782
  • P50MD017342 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Non-identifiable data will be deposited into the University of Minnesota Data Repository (DRUM)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on chatbot

Subscribe